POSA133 Cost-Effectiveness of Dapagliflozin for the Treatment of Heart Failure with Reduced Ejection Fraction: Analyses from the Perspectives of France and the United States

Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.276
https://www.valueinhealthjournal.com/article/S1098-3015(21)02071-4/fulltext
Title : POSA133 Cost-Effectiveness of Dapagliflozin for the Treatment of Heart Failure with Reduced Ejection Fraction: Analyses from the Perspectives of France and the United States
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02071-4&doi=10.1016/j.jval.2021.11.276
First page :
Section Title :
Open access? : No
Section Order : 11056
Categories :
Tags :
Regions :
ViH Article Tags :